NCT03643627View on ClinicalTrials.gov

A Study of SYNT001 in Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 17, 2016

Primary Completion Date

April 13, 2017

Study Completion Date

April 13, 2017

Conditions
Healthy
Interventions
DRUG

SYNT001

single IV infusion

DRUG

Placebo

single IV infusion

Trial Locations (1)

33014

Clinical Pharmacology of Miami, Miami

All Listed Sponsors
lead

Syntimmune, Inc.

INDUSTRY

NCT03643627 - A Study of SYNT001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter